Analysts' Views: Developments for Airbus, Thales, Saint-Gobain...

Above their target: 4 stocks · SBF 120 stocks covered: 119

Stocks above their target: Rémy Cointreau (-5.7%) · Teleperformance (-4.9%) · bioMérieux (-3.4%) · Eurofins Scientific (-3.3%)

Accor: from 54 to 55 euros at Barclays, which adjusts its target by one euro. Median target at 55 euros for 8 analysts, Target/price gap: +20.7%. One analyst had raised its target on October 2, another had lowered it.

On the ING side, it is Barclays that raised its target from 32.50 to 34.10 euros. The median stands at 35.04 euros, Target/price gap: +18.5%. One analyst had raised its target on October 5.

At Wolters Kluwer, Barclays reduces its target from 110 to 90 euros. Consensus median at 95 euros (8 analysts), Target/price gap: +28.8%.

Ubisoft Entertainment: Barclays is at "market weight", with a target raised from 5.45 to 5.85 euros. Median at 5.52 euros, Target/price gap: +8.7%.

Two brokers weigh in on Air France-KLM: Barclays shifts from "underweight" to "sell" and cuts its target from 12 to 9 euros, while Rothschild & Co Redburn is at "buy" with a target reduced from 18 to 17 euros. Two analysts had lowered their targets, with the latest movement dating from October 8. Median at 12 euros, Target/price gap: +9.4%.

From 40.30 to 36.90 euros: Veolia sees its target trimmed by Intesa Sanpaolo, which remains on buy. Three analysts had lowered their targets over the last 10 days (latest movement on October 7). Median at 37 euros, Target/price gap: +19%.

Still on buy, BofA Securities lowers its target on EssilorLuxottica from 237 to 205 euros. Six analysts had already lowered their targets over the last 10 days, the latest on October 6. The median target stands at 205 euros (14 analysts), Target/price gap: +38.9%.

Aegon: ING Wholesale, still on buy, raises its target from 7.40 to 9.15 euros. Median at 8.09 euros, Target/price gap: +9%.

A more modest target decline at Magnum: ING Wholesale, which remains on buy, shifts from 18.80 to 18.50 euros. Median at 17 euros, Target/price gap: +9.1%.

No target movement at Airbus: CIC Market Solutions remains on buy with a target of 240 euros. The median target at 240 euros for 17 analysts shows a Target/price gap of +27.8%.

Same scenario for Thales: CIC Market Solutions confirms its buy advice, target of 305 euros unchanged. One analyst had raised its target and two had lowered theirs over the last 10 days (latest movement on October 8). Median at 288 euros, Target/price gap: +32.9%.

Divergence at Saint-Gobain: CIC Market Solutions remains on buy with a target of 100 euros, while RBC Capital shifts from "outperform" to "sector perform" and reduces its target from 97 to 80 euros. Six analysts had lowered their targets over the last 10 days, the latest on October 7. Median at 95 euros, Target/price gap: +45.2%.

Getlink: CIC Market Solutions remains on buy (target 21 euros, unchanged), UBS confirms its "hold" advice by adjusting its target from 19.80 to 19.60 euros. Median at 19.90 euros, Target/price gap: +6.1%.

At GTT, CIC Market Solutions remains on buy and leaves its target at 238 euros. Identical median at 238 euros (10 analysts), Target/price gap: +11.1%.

Two brokers on ArcelorMittal: UBS shifts from "market perform" to "buy" and raises its target from 61 to 71 euros, while Oddo BHF, at "outperform", lowers its target from 76 to 74 euros. Two analysts had raised and two lowered their targets over the last 10 days (latest movement on October 6). Median at 71 euros, Target/price gap: +24.7%.

UBS also adjusts its targets on three stocks, confirming its opinion each time:
- Stellantis: still on "hold", target reduced from 5.80 to 4.50 euros. Median at 5.38 euros, Target/price gap: +33%.
- Alstom: "hold" opinion is confirmed, target shifts from 24 to 18 euros. Median at 18.39 euros, Target/price gap: +16.8%.
- Forvia: still on "hold", target from 14 to 10.50 euros. Median at 12.50 euros, Target/price gap: +43.7%. One analyst had raised its target on October 7.

Morgan Stanley is on "underweight" on bioMérieux, with a target of 71 euros versus 66 euros previously. The median target (80 euros) sits below the price: Target/price gap: -3.4%.

Soitec: Bank of America is on "buy", target 300 euros. The median target is 175 euros, Target/price gap: +7.1%. One analyst had raised its target on September 30.

On Rémy Cointreau, Deutsche Bank remains on "sell" and raises its target from 38 to 40 euros. Median at 41 euros, Target/price gap: -5.7%. One analyst had raised its target on October 8.

Still on buy, Deutsche Bank raises its target on Euronext from 184 to 192 euros. Three analysts had raised their targets over the last 10 days (latest movement on October 8). Median at 171 euros, Target/price gap: +4.1%.

From 82 to 65 euros at Pernod Ricard: Rothschild & Co Redburn, at "neutral", significantly cuts its target. The median target is set at 70 euros for 14 analysts, Target/price gap: +14.5%. One analyst had raised its target on September 29.

Two brokers on "buy" on Nexans: JP Morgan raises its target from 183 to 186 euros, HSBC lowers it from 180 to 175 euros. Median at 175 euros (12 analysts), Target/price gap: +36.7%.

Bureau Veritas: Citi shifts from "neutral" to "buy" and raises its target from 31.44 to 31.54 euros. One analyst had raised and another lowered its target over the last 10 days (latest movement on October 6). Median at 32.20 euros, Target/price gap: +19.9%.

Goldman Sachs, on "buy", reduces its target on Argenx from 982 to 954 euros. One analyst had lowered its target on October 8. Median at 986.50 euros (5 analysts), Target/price gap: +32.7%.

It is Jefferies that at Amundi is on "buy" with a target raised from 95 to 105 euros. Three analysts had raised and two lowered their targets over the last 10 days (latest movement on October 8). Median at 98.60 euros, Target/price gap: +12.4%.

Odyssée Technologie: Greensome Finance remains on buy with an unchanged target of 33.38 euros, sole consensus analyst. Target/price gap: +106%.

Finally, All Invest Securities is on "buy" on ABL Diagnostics, target 8.70 euros. Median at 8.62 euros for 3 analysts, Target/price gap: +291.8%.